Developing a mouse model of acute encephalopathy using low-dose lipopolysaccharide injection and hyperthermia treatment

Exp Biol Med (Maywood). 2019 Jun;244(9):743-751. doi: 10.1177/1535370219846497. Epub 2019 May 2.

Abstract

Acute encephalopathy (AE), mainly reported in East Asia, is classified into four categories based on clinical and neuropathological findings. Among them, AE caused by cytokine storm is known as the severest clinical entity that causes cerebral edema with poor prognosis. Because suitable and convenient model animal of AE had not been developed, the treatment of patients with AE is not established. In the present study, we established a simple and convenient protocol to mimic AE due to cytokine storm. Our model animal should be useful to elucidate the pathogenesis of AE.

Keywords: Hyperthermia; acute encephalopathy; blood–brain barrier; lipopolysaccharide; seizure; vasogenic edema.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Febrile Encephalopathy / etiology*
  • Acute Febrile Encephalopathy / pathology
  • Acute Febrile Encephalopathy / physiopathology
  • Animals
  • Animals, Newborn
  • Astrocytes / pathology
  • Blood-Brain Barrier / pathology
  • Brain / pathology
  • Brain / physiopathology
  • Brain / ultrastructure
  • Disease Models, Animal*
  • Fever / complications*
  • Lipopolysaccharides / administration & dosage
  • Lipopolysaccharides / pharmacology*
  • Mice
  • Mice, Inbred ICR
  • Microscopy, Confocal

Substances

  • Lipopolysaccharides